scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00198-011-1664-4 |
P698 | PubMed publication ID | 21691843 |
P50 | author | Ego Seeman | Q41546810 |
Dennis M Black | Q92034930 | ||
P2093 | author name string | L Palermo | |
S Burch | |||
C Bucci-Rechtweg | |||
R Wustrack | |||
P2860 | cites work | Denosumab for prevention of fractures in postmenopausal women with osteoporosis | Q28254528 |
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis | Q29619487 | ||
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study | Q30885864 | ||
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group | Q33926440 | ||
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis | Q34003925 | ||
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. | Q34319046 | ||
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group | Q34409983 | ||
Long-term risk of incident vertebral fractures | Q34731698 | ||
Fragility fractures and the osteoporosis care gap: an international phenomenon. | Q36449722 | ||
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures | Q36597363 | ||
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study | Q37407722 | ||
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. | Q40263627 | ||
Prognostic utility of a semiquantitative spinal deformity index | Q40418590 | ||
A meta-analysis of previous fracture and subsequent fracture risk | Q40494142 | ||
Characteristics of a prevalent vertebral deformity predict subsequent vertebral fracture: results from the European Prospective Osteoporosis Study (EPOS). | Q40556546 | ||
Risk of new vertebral fracture in the year following a fracture | Q40727530 | ||
Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group | Q40814126 | ||
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group | Q41697049 | ||
The association of radiographically detected vertebral fractures with back pain and function: a prospective study | Q43602714 | ||
Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly--a 12- and 22-year follow-up of 257 patients | Q43756291 | ||
Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group | Q44168260 | ||
The risk and burden of vertebral fractures in Sweden | Q44494299 | ||
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial | Q44614799 | ||
The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population | Q44643763 | ||
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. | Q44961457 | ||
Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures. | Q45955824 | ||
Vertebral fracture assessment using a semiquantitative technique. | Q45969757 | ||
Spinal deformity index (SDI) is a good predictor of incident vertebral fractures | Q46167288 | ||
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group | Q46315882 | ||
The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women. | Q51925121 | ||
A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis | Q69849414 | ||
Epidemiology of osteoporotic fractures | Q80559669 | ||
Mild prevalent and incident vertebral fractures are risk factors for new fractures | Q80568968 | ||
The care gap in diagnosis and treatment of women with a fragility fracture | Q80643748 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 53-58 | |
P577 | publication date | 2011-06-21 | |
P1433 | published in | Osteoporosis International | Q7107640 |
P1476 | title | Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial | |
P478 | volume | 23 |
Q38035923 | Balloon kyphoplasty in patients with osteoporotic vertebral compression fractures |
Q49826086 | Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature |
Q37617445 | Influence of insurance benefit criteria on the administration rate of osteoporosis drugs in postmenopausal females |
Q88786485 | Maternal nutrition and the developmental origins of osteoporosis in offspring: Potential mechanisms and clinical implications |
Q45340442 | Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial |
Q33969649 | Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients' bone health |
Q36588456 | Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial |
Q50801005 | Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women. |
Q39392004 | Prevalent vertebral fractures on chest CT: higher risk for future hip fracture |
Q55497139 | The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis. |
Search more.